IL125795A0 - Retroviral vectors encoding a cytochrome p450 gene - Google Patents

Retroviral vectors encoding a cytochrome p450 gene

Info

Publication number
IL125795A0
IL125795A0 IL12579597A IL12579597A IL125795A0 IL 125795 A0 IL125795 A0 IL 125795A0 IL 12579597 A IL12579597 A IL 12579597A IL 12579597 A IL12579597 A IL 12579597A IL 125795 A0 IL125795 A0 IL 125795A0
Authority
IL
Israel
Prior art keywords
cytochrome
gene
retroviral vectors
vectors encoding
capsules
Prior art date
Application number
IL12579597A
Other languages
English (en)
Original Assignee
Bavarian Nordic Res Inst As
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL125795(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic Res Inst As, Gsf Forschungszentrum Umwelt filed Critical Bavarian Nordic Res Inst As
Publication of IL125795A0 publication Critical patent/IL125795A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C12N9/0079—Steroid 11 beta monooxygenase (P-450 protein)(1.14.15.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12579597A 1996-03-27 1997-03-27 Retroviral vectors encoding a cytochrome p450 gene IL125795A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK35296 1996-03-27
PCT/EP1997/001585 WO1997035994A2 (en) 1996-03-27 1997-03-27 Cytochrome p450 transducing retroviral vectors

Publications (1)

Publication Number Publication Date
IL125795A0 true IL125795A0 (en) 1999-04-11

Family

ID=8092560

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12579597A IL125795A0 (en) 1996-03-27 1997-03-27 Retroviral vectors encoding a cytochrome p450 gene

Country Status (19)

Country Link
US (1) US6893634B1 (xx)
EP (1) EP0892852B1 (xx)
JP (1) JP4229982B2 (xx)
AT (1) ATE309383T1 (xx)
AU (1) AU713382B2 (xx)
CA (1) CA2250173A1 (xx)
CZ (1) CZ288074B6 (xx)
DE (1) DE69730595D1 (xx)
DK (1) DK0892852T3 (xx)
ES (1) ES2253775T3 (xx)
HU (1) HU221349B1 (xx)
IL (1) IL125795A0 (xx)
NO (1) NO325392B1 (xx)
NZ (1) NZ331765A (xx)
PL (1) PL188323B1 (xx)
RU (2) RU2223788C2 (xx)
SI (1) SI0892852T1 (xx)
SK (1) SK282744B6 (xx)
WO (1) WO1997035994A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU708273B2 (en) 1995-06-27 1999-07-29 Bavarian Nordic A/S Encapsulated cells producing viral particles
RU2223788C2 (ru) 1996-03-27 2004-02-20 Бавариан Нордик Рисерч Инститьют А/С Трансдуцирующие цитохром p450 ретровирусные векторы
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
EP1115871A2 (en) * 1998-09-21 2001-07-18 Transgene S.A. Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
GB0400443D0 (en) 2004-01-09 2004-02-11 Oxford Biomedica Ltd Cascade
AU1869900A (en) * 1999-01-04 2000-07-24 Ml Laboratories Plc P450/acetaminophen GDEPT for cancer treatment
GB9900009D0 (en) * 1999-01-04 1999-02-24 Ml Lab Plc Gene therapy
GB0010105D0 (en) * 2000-04-26 2000-06-14 Ml Lab Plc Cell ablation
EP1427836A2 (en) * 2001-09-21 2004-06-16 Oxford Biomedica (UK) Limited Pseudotyped retroviral vector system
GB201408233D0 (en) 2014-05-09 2014-06-25 Austrianova Singapore Pte Ltd Use of polyanionic composition
MX2015006813A (es) * 2015-05-29 2016-11-28 Univ Nac Autónoma De México Nanoparticulas biocataliticas cyp-p22 con actividad citocromo p450 para la activacion de profarmacos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68927089T2 (de) 1988-05-17 1997-04-03 Sloan Kettering Inst Cancer Retroviraler vektor
WO1994029437A1 (en) 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
JP4037446B2 (ja) 1994-09-02 2008-01-23 ゲーエスエフ − フォルシュンクスツェントルム・フューア・ウムベルト・ウント・ゲズントハイト・ゲーエムベーハー 非自己不活化性の発現標的化レトロウイルスベクタ
AU708273B2 (en) 1995-06-27 1999-07-29 Bavarian Nordic A/S Encapsulated cells producing viral particles
ES2174103T3 (es) * 1995-09-06 2002-11-01 Austrian Nordic Biotherapeutic Uso de las secuencias reguladoras de wap o mmtv para expresion dirigida de genes heterologos ligados en celulas mamarias humanas, con inclusion de celulas de carcinoma mamario humano.
RU2223788C2 (ru) 1996-03-27 2004-02-20 Бавариан Нордик Рисерч Инститьют А/С Трансдуцирующие цитохром p450 ретровирусные векторы

Also Published As

Publication number Publication date
NO984540L (no) 1998-09-28
EP0892852B1 (en) 2005-11-09
PL188323B1 (pl) 2005-01-31
PL329071A1 (en) 1999-03-15
NO984540D0 (no) 1998-09-28
CZ305098A3 (cs) 1999-01-13
HUP9904116A2 (hu) 2000-04-28
RU2185821C2 (ru) 2002-07-27
SI0892852T1 (sl) 2006-04-30
NZ331765A (en) 2000-02-28
ES2253775T3 (es) 2006-06-01
WO1997035994A2 (en) 1997-10-02
DE69730595D1 (de) 2004-10-14
HU221349B1 (en) 2002-09-28
CZ288074B6 (cs) 2001-04-11
JP2000509249A (ja) 2000-07-25
JP4229982B2 (ja) 2009-02-25
NO325392B1 (no) 2008-04-21
HUP9904116A3 (en) 2001-01-29
SK132398A3 (en) 1999-04-13
WO1997035994A3 (en) 1997-11-20
EP0892852A2 (en) 1999-01-27
US6893634B1 (en) 2005-05-17
AU713382B2 (en) 1999-12-02
ATE309383T1 (de) 2005-11-15
RU2223788C2 (ru) 2004-02-20
DK0892852T3 (da) 2006-03-06
AU2382797A (en) 1997-10-17
SK282744B6 (sk) 2002-12-03
CA2250173A1 (en) 1997-10-02

Similar Documents

Publication Publication Date Title
HUP0203238A3 (en) Drugs for the treatment of malignant tumours, process for their preparation and pharmaceutical compositions containing them
RO118928B1 (ro) Compoziţie farmaceutică cu modafinil
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
HK1028594A1 (en) Adamantane derivatives
PL340906A1 (en) Adamantane derivatives
HUP0201711A2 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
HUP0001116A3 (en) Disubstituted bicyclic heterocycle, pharmaceutical compositions containing them and process for producing them
MY125978A (en) Admantane derivatives
EP1060738A3 (en) Self-tanning composition comprising carmine
HRP20010115B1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
TR200001544T2 (tr) Yeni bileşikler.
IL125795A0 (en) Retroviral vectors encoding a cytochrome p450 gene
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
AU2596600A (en) Modified hiv env polypeptides
BG103714A (en) Pararacetamol-containing tablet
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
WO2000008007A3 (de) Cyclopentabenzofuran-derivate und ihre verwendung
IL148003A0 (en) Floating pharmaceutical composition comprising an active phase and a non-active phase
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
AU2164197A (en) Recombinant adenoviral vectors for human tumour gene therapy
ZA938709B (en) Multifunctional neurotrophic factors
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama
HUP0100384A3 (en) Medicaments containing micronized benzopyrane and pyridopyrane drugs, use of them, and process for producing them

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired